Last reviewed · How we verify
NCT06154798
World Digital Detox Program for Enhancing Women's Health & Well-being
NA trial testing World Digital Detox Women's Health Program in Menopause in 73 participants. Completed in 30 July 2023.
30 June 2023
Quick facts
| Lead sponsor | Innowage Limited |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 73 |
| Start date | 16 January 2023 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 July 2023 |
| Sites | 1 location across India |
Drugs / interventions tested
- World Digital Detox Women's Health Program
Conditions studied
- Menopause — all drugs for Menopause →
- Menopause Related Conditions — all drugs for Menopause Related Conditions →
- Psychological Stress — all drugs for Psychological Stress →
Sponsor
Innowage Limited
Who can join
Adults 40 to 65, female only, with Menopause or Menopause Related Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The concept of a digital detox, involving a deliberate reduction or elimination of digital device usage, has emerged as a potential strategy to mitigate the adverse effects of technology on mental and physical well-being. However, the specific effects of a structured digital detox program on psychological distress, psychosocial factors, menopause symptoms, and overall physical health in a community context remain underexplored. This study seeks to address this gap by conducting a real-world trial, examining the impact of a digital detox program tailored for women. By delving into the intricacies of how digital technology interacts with the unique challenges faced by women, this research aims to contribute valuable insights into the development of real-world-driven interventions that promote the holistic well-being of women in the digital age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06154798
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menopause
Currently open trials in the same condition.
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
- NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
- NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting
Other Innowage Limited trials
Trials by the same sponsor.
- NCT06760286 — Breathe-Easy: Food Supplement for Respiratory Health · NA · completed
- NCT06765239 — Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis · NA · completed
- NCT05795322 — Acute Effect of Sound Healing on Pain, Fatigue and Mood · completed
- NCT06154681 — World Digital Detox Program for Enhancing Youth and Family Well-being · NA · completed
- NCT05715554 — Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06154798 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Innowage Limited
- Last refreshed: 4 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06154798.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing